reports
DANONE: Completion by Danone of the sale of its EDP business in Russia
DANONE: Completion by Danone of the sale of its EDP business in Russia Press release – Paris, May 17, 2024 Completion by Danone of the sale of its EDP business in Russia Following the press release on March 22, 2024, where Danone announced that the Russian regulatory approvals required for the disposal of its EDP business in Russia to Vamin R LLC were obtained, Danone announces today it has completed this transaction. About Danone () Danone is a leading global food and beverage company operating in three health-focused, fast-growing and on-trend Categories: Essential Dairy & Plant-Based...
Danone finalise la cession de ses activités EDP en Russie
Danone finalise la cession de ses activités EDP en Russie Communiqué de presse – Paris, le 17 mai 2024 Danone finalise la cession de ses activités EDP en Russie Danone annonce aujourd’hui avoir réalisé la cession de ses activités EDP en Russie à Vamin R LLC, faisant suite à l’obtention des autorisations réglementaires russes requises - comme annoncé dans le communiqué de presse du 22 mars. A propos de Danone () Danone est une entreprise leader de l’alimentation, qui opère dans trois Catégories en forte croissance et axées sur la santé à travers les Produits Laitiers et d’Origine Végéta...
L''Oreal: 1 director
A director at L'Oreal sold 9,976 shares at 455.000EUR and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing...
Danone: Information on the total number of voting rights and shares
Danone: Information on the total number of voting rights and shares DANONE French Société anonyme with a capital of €169,443,282,00. Registered Office: 17, boulevard Haussmann, 75009 Paris. Registered with the Paris Commerce and Company Registry under number 552 032 534 Information on the total number of voting rights and shares in compliance with Article L. 233-8 II of the French Commercial Code and with Article 223-16 of the General Regulation of the Financial Markets Authority (AMF- Autorité des Marchés Financiers) DateTotal number of sharesTotal number of voting rights 30/04/2024...
DANONE : Informations relatives au nombre total de droits de vote et d...
DANONE : Informations relatives au nombre total de droits de vote et d’actions DANONE Société anonyme à Conseil d’Administration au capital de 169 443 282,00 €.Siège social : 17, boulevard Haussmann, 75009 Paris.552 032 534 R.C.S. Paris. Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L. 233-8 II du code de commerce et l’article 223-16 du règlement général de l’Autorité des marchés financiers DateNombre d’actionsNombre total de droits de vote30/04/2024677 773 128Nombre de droits de vote théoriques (1) : 698 764 592Nombre de droit de votes exer...
- Jesper Ingildsen
Royal Unibrew (Buy, TP: DKK625.00) - In a position of strength
Yesterday we attended Royal Unibrew’s CMD in the Netherlands. We found the event informative, especially about recent years’ acquisitions in Norway and the Netherlands. Our impression was that momentum is strong, and that the recent long-term organic EBIT target of 6–8% growth could be conservative. Following years of headwinds, the company seems to be emerging in a stronger position than ever. We reiterate our BUY and DKK625 target price.
- ING Helpdesk
Benelux Morning Notes
ABN AMRO: 1Q24 Preview. ABN AMRO: Press reports on sale of French Life Neuflize JV with AXA. Agfa-Geveart: A miss on every line. ASR: Dutch residential rental income risk insignificant. B&S Group: Solid start to the year, costs under control. DEME Group: 1Q solidifies FY24 revenue outlook. GBL: Accelerating its share buybacks. Just Eat Takeaway.com: M&A appetite. OCI: Improving 1Q24 performance at RemainCo assets, strategic update due on 2Q24
- Michael Roeg
- ABGSC Food & Beverage Research
- Peter Sehested
- Cedric Rossi
- Clement Genelot
- Loic Morvan
- Paul Rouviere
- Philippine Adam
On the shelves now: Consumer weekly #28
In this Consumer Weekly newsletter, we provide a brief overview of the key factors affecting our Consumer coverage, from Luxury & Consumer goods to Retail & E-commerce and Food & Ingredients. This week, we comment about the positive stock market trend in spite of constant delays in Fed
Launch of Long-Term Incentive Plan for executive management and key em...
Launch of Long-Term Incentive Plan for executive management and key employees COMPANY ANNOUNCEMENT NO 14/2024 – MAY 13, 2024 Royal Unibrew A/S launches a new share based Long-Term Incentive Plan (LTIP) for selected key employees for 2024 designed to align the interests of Royal Unibrew’s employees and shareholders and to retain employees. The new LTIP for 2024 has been approved by the Board of Directors. The LTIP is based on Performance Share Units (PSU) granted to each key employee. The PSUs are granted in 2024 for vesting on the date the Board of Directors approves and makes public the ...
- Cedric Rossi
US eyewear: Distinct Q1 trajectories between NV and Warby Parker
Except for National Vision which faced company-specific issues, Q1 proved to be a reassuring vintage for most optical players, despite several headwinds such as the "Artic Blast" in January and the earlier Easter that mainly impacted prescription sales. Relative optimism continues to prevail for 20
- Cedric Rossi
Safilo: Q1 less negative than feared and reassuring month of April
The Q1 sales decline of 1.8% FX-n was less damaging than our -4.6% FX-n figure (see our preview here) thanks to a stronger-than-expected performance in Europe. Q1 aEBITDA margin also surprised positively with a 20bp-improvement to 11.5% (CSSe: 11.2% / BGe: 11.3%). Management confirmed a return to p
- ABGSC Food & Beverage Research
- Peter Sehested
Nestlé SA: 1 director
A director at Nestlé SA bought 500 shares at 91.106CHF and the significance rating of the trade was 55/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showin...
- Cedric Rossi
- Clement Genelot
- Loic Morvan
- Paul Rouviere
- Philippine Adam
On the shelves now: Consumer weekly #27
In this Consumer Weekly newsletter, we provide a brief overview of the key factors affecting our Consumer coverage, from Luxury & Consumer goods to Retail & E-commerce and Food & Ingredients. This week, we take a look at the Q1 earnings season in the US, which is set to be a good vintag
Givaudan SA: 1 director
A director at Givaudan SA sold 17 shares at 3,992.118CHF and the significance rating of the trade was 55/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly show...
- Cedric Rossi
Fielmann: Reassuring start to the year
With Q1 sales and EBITDA both up 11% YoY, FIE has reassured the market despite a demanding comparison base and challenging macro environment, particularly in Germany. Similarly, FY24 sales outlook highlights robust top-line trends through the year, whilst FIE's prudent EBITDA target leaves some ups
Danone acquires Functional Formularies
Danone acquires Functional Formularies Press release – Paris, May 01, 2024 Danone acquires Functional Formularies Danone announces today it has successfully completed the acquisition of Functional Formularies, a leading whole foods tube feeding business in the US, from Swander Pace Capital. As part of the Renew Danone strategy, this acquisition strengthens Danone’s Medical Nutrition portfolio in the US by further expanding its enteral tube feeding ranges. Juergen Esser, Deputy CEO and CFO, said: “As a global leader in Medical Nutrition, we are delighted to welcome Functional Formularie...
Danone acquiert Functional Formularies
Danone acquiert Functional Formularies Communiqué de presse – Paris, le 1er mai 2024 Danone acquiert Functional Formularies Danone annonce aujourd’hui avoir réalisé l’acquisition de Functional Formularies, leader aux Etats-Unis de l’alimentation par sonde à base d’aliments, auprès de Swander Pace Capital. Dans le cadre de la stratégie Renew Danone, cette acquisition renforce le portefeuille de Danone en Nutrition Médicale aux Etats-Unis, élargissant sa gamme d’alimentation entérale. Juergen Esser, Directeur Général Adjoint et Directeur Financier : « Nous sommes ravis d'accueillir Funct...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.